The science behind niacinamide in compounded tirzepatide Understanding why niacinamide is included in compounded tirzepatide requires exploring its biochemical roles and the preclinical evidence suggesting metabolic benefits
Moreover, SFN treatment significantly reduced the overall PASI score compared with the IMQ group, indicating the protective effects of SFN on psoriasis
Nature 436 , 112116 (2005)
Combination therapy has several potential advantages, including (1) increased durability of the glycaemic effect [225,226,227], addressing therapeutic inertia, (2) simultaneous targeting of the multiple pathophysiological processes characterised by type 2 diabetes, (3) impacts on medication burden, medication-taking behaviour and treatment persistence and (4) complementary clinical benefits (e.g
Curious how other clinicians here are thinking about this gap, and whether its narrowing or widening